openPR Logo
Press release

Glycated Albumin Assay Market New Trends, Size, Share, Top Companies, Industry Analysis, Advance Technology, Future Development & Forecast - 2028

12-13-2024 07:50 PM CET | Health & Medicine

Press release from: ABNewswire

The major players operating in this market are Asahi Kasei Corporation (Japan), Beijing Strong Biotechnologies, Inc. (China), Diazyme Laboratories, Inc. (US), DxGen Corp. (South Korea), Weldon Biotech (India), Hzymes Biotech (China).

The major players operating in this market are Asahi Kasei Corporation (Japan), Beijing Strong Biotechnologies, Inc. (China), Diazyme Laboratories, Inc. (US), DxGen Corp. (South Korea), Weldon Biotech (India), Hzymes Biotech (China).

Browse 70 market data Tables and 33 Figures spread through 126 Pages and in-depth TOC on "Glycated Albumin Assay Market by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User (Hospitals & Diabetic Care Center, Diagnostic Laboratory) & Region (North America, Europe, APAC, Latin America, & MENA) - Global Forecast to 2028
Glycated Albumin Assay Market [https://www.marketsandmarkets.com/Market-Reports/glycated-albumin-assay-market-265553363.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $0.2 billion in 2023 and is poised to reach $0.3 billion by 2028, growing at a CAGR of 8.9% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . Government assistance is stimulating the market. Players in the glycated albumin assay market have significant potential in developing nations like India and Japan.

Additionally, the aging population in developed and developing nations would favorably impact the market for glycated albumin assay. The prevalence of age-related illnesses like diabetes and pancreatic disorders is anticipated to rise dramatically as the senior population is forecast to grow quickly. Numerous test prescriptions to assess the levels of creatinine, albumin, glucose, ketones, and bilirubin are caused by diagnosing and treating such disorders, which is driving the market's expansion. Browse through 100 market data tables and 44 figures spread across 180 pages and the in-depth TOC of the glycated albumin assay market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265553363 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265553363&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

The type 2 diabetes segment accounted for the largest share of the glycated albumin assay market, by application segment, in 2022

Based on application, the glycated albumin assay market is segmented into prediabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes segment accounted for the largest share of the glycated albumin assay market, mainly due to increased focus on type 2 diabetes care and increased funding for diagnostic research.

Hospitals and diabetes care centers segment to register the highest growth rate during the forecast period

The significant market share of this sector is mostly due to an increased emphasis on early disease diagnosis. Additionally, hospitals and diabetes care facilities are committed to providing patients with diabetes-specialized care. Their focus on comprehensive diabetes care makes them primary locations for conducting glycated albumin assays, which are important diagnostic tests for monitoring glycemic control.

North America is the largest regional market during the forecast period

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the five main geographic segments of the worldwide glycated albumin assay market. In 2022, the glycated albumin assay market's largest regional market was North America. The government's support for regional research and increased funding for the creation of preventive care diagnostics can be used to explain North America's significant market dominance.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265553363 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=265553363&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Glycated Albumin Assay Market Dynamics:

Drivers:

* Rising prevalence of diabetes

Restraints:

* Unfavorable reimbursement scenario

Opportunities:

* Rising investments in healthcare and life sciences research

Challenges:

* Changing regulatory landscape

Key Market Players:

The major players operating in this market are Asahi Kasei Corporation (Japan), Beijing Strong Biotechnologies, Inc. (China), Diazyme Laboratories, Inc. (US), DxGen Corp. (South Korea), Weldon Biotech (India), Hzymes Biotech (China).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=265553363 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=265553363&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Glycated Albumin Assay Market Advantages:

* Early Glycemic Control Assessment: Glycated albumin testing provides an early and accurate assessment of glycemic control. Unlike HbA1c, which reflects long-term glucose levels, glycated albumin measurements reflect shorter-term changes in blood glucose levels, typically over the preceding two to three weeks. This allows for timely intervention and adjustment of treatment plans, enabling healthcare providers to optimize diabetes management and reduce the risk of complications.
* Sensitivity to Glycemic Variability: Glycated albumin assays are highly sensitive to glycemic variability. They can detect rapid fluctuations in blood glucose levels, providing a more dynamic representation of glycemic control. This sensitivity is particularly important for patients with conditions such as gestational diabetes, diabetes in children, and those with brittle diabetes who experience wide fluctuations in blood sugar levels.
* Independence from Hemoglobin Variants: Unlike HbA1c, which can be affected by hemoglobin variants and conditions like anemia, glycated albumin measurements are not influenced by these factors. This independence ensures more accurate and reliable results, eliminating potential confounding factors and allowing for consistent monitoring of glycemic control across different patient populations.
* Rapid Turnaround Time: Glycated albumin assays offer rapid turnaround times compared to other glycemic control markers. Results can be obtained within hours, providing timely information for clinical decision-making. This quick feedback is particularly valuable in emergency situations, postprandial monitoring, and for assessing treatment efficacy in real-time.
* Personalized Medicine Approach: The glycated albumin assay supports a personalized medicine approach to diabetes management. It allows for individualized treatment plans based on a patient's unique glycemic patterns, helping to optimize therapies and achieve better glycemic control. This personalized approach can lead to improved patient outcomes and quality of life.
* Integration with Digital Health Solutions: The glycated albumin assay can be integrated with digital health solutions and electronic medical records, enabling seamless data management and analysis. This integration facilitates remote monitoring, data sharing between healthcare providers and patients, and the generation of personalized reports and trends, enhancing patient engagement and self-management.
* Market Growth Potential: With the increasing prevalence of diabetes worldwide, the glycated albumin assay market has substantial growth potential. The demand for accurate and reliable glycemic control monitoring tools is rising, driven by the need for effective diabetes management, early intervention, and risk reduction. This market growth presents opportunities for innovation, technological advancements, and improved accessibility of glycated albumin testing.

In summary, the glycated albumin assay market offers advantages such as early glycemic control assessment, sensitivity to glycemic variability, independence from hemoglobin variants, rapid turnaround time, personalized medicine approach, integration with digital health solutions, and significant growth potential. These advantages contribute to the growing importance of glycated albumin assays in diabetes management and highlight their potential to improve patient care and outcomes.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=glycated-albumin-assay-market-new-trends-size-share-top-companies-industry-analysis-advance-technology-future-development-forecast-2028]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/glycated-albumin-assay-market-265553363.html



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycated Albumin Assay Market New Trends, Size, Share, Top Companies, Industry Analysis, Advance Technology, Future Development & Forecast - 2028 here

News-ID: 3787584 • Views:

More Releases from ABNewswire

Cheapest Detroit Pistons vs. Rivals Tickets at Little Caesars Arena - CITY10 Promo Code Deals at CapitalCityTickets.com
Cheapest Detroit Pistons vs. Rivals Tickets at Little Caesars Arena - CITY10 Pro …
Get the cheapest Detroit Pistons tickets for games against top rivals at Little Caesars Arena! Use promo code CITY10 at CapitalCityTickets.com to unlock exclusive discounts. Compare seating options, secure your spot courtside, and enjoy live NBA action without overspending. Don't miss thrilling Pistons matchups-grab your discounted tickets today and experience the excitement of every game! The 2025-26 NBA season is here, and the Detroit Pistons are ready to ignite Little Caesars
Precision in Healthcare Communication: Why ITA Members Are the Right Choice for Medical Translation
10-05-2025 | Sports
ABNewswire
Precision in Healthcare Communication: Why ITA Members Are the Right Choice for …
Medical translation requires absolute accuracy, specialized knowledge, and sensitivity to cultural and linguistic differences. Members of the Israel Translators Association (ITA) bring expertise in medicine, pharmaceuticals, and healthcare, ensuring that clinical trials, patient records, and medical device manuals are translated with precision and confidentiality. Choosing an ITA member guarantees professional standards and dependable results in this critical field In medicine, words can save lives-or put them at risk. Accurate communication is
Best Deals on 2025 Milwaukee Bucks NBA Tickets - Use Promo CITY10 Online at CapitalCityTickets.com
Best Deals on 2025 Milwaukee Bucks NBA Tickets - Use Promo CITY10 Online at Capi …
Get the best deals on 2025 Milwaukee Bucks tickets at CapitalCityTickets.com! Choose from a wide selection of seat levels and enjoy even greater savings by applying promo code CITY10 at checkout. Secure your tickets now and cheer on the Bucks live at Fiserv Forum or on the road-while seats last! Looking for the best deals on Milwaukee Bucks NBA tickets for the 2025-26 season? You can score affordable tickets to see
Affordable Montreal Canadiens Bell Centre Tickets Online - Save with Promo Code CITY10 on the Best Site CapitalCityTickets.com
Affordable Montreal Canadiens Bell Centre Tickets Online - Save with Promo Code …
Score affordable Montreal Canadiens tickets at Bell Centre! Use promo code CITY10 at CapitalCityTickets.com to save on your seats. Compare ticket options, find the best views, and secure your spot to watch the Canadiens live. Don't miss top NHL action-grab discounted tickets today and enjoy thrilling hockey games without overspending! As the 2025-26 NHL season ignites, the Montreal Canadiens are gearing up to light up the Bell Centre with their signature

All 5 Releases


More Releases for Biotech

Global Agricultural Biotech Market Analysis By Top Keyplayers - Agriland Biotech …
Market Overview The global agricultural biotech market, valued at USD 103.2 billion in 2023, is projected to reach USD 213.3 billion by 2031, growing at a CAGR of 9.5% from 2024 to 2031. Biotechnology in agriculture enhances productivity through genetic modification, producing crops with higher yields, pest and disease resistance, and better nutritional content. Recent advancements like CRISPR-Cas9 have revolutionized crop development, offering precise and efficient genetic enhancements. Emerging markets with
By Company Kingherbs Artemis NutriBotanica Kemin Vita Forte Alpspure Reindeer Bi …
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global Acerola Cherry Extract Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global Acerola Cherry Extract market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides
Phycobiliproteins Market | Aim Grow Biotech Co., Ltd, Algapharma Biotech, Algene …
The global phycobiliproteins market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the phycobiliproteins market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the phycobiliproteins market.
Biotechnology-Based Chemical Market Size 2022: Kemin Europa, Clariant, JC Biotec …
Biotechnology-Based Chemical Market research report provides valuable insights by analyzing market trends and market scenarios over a defined period. It also presents manufacturing details like sales, volume, revenue, price, and gross margin. Furthermore, the import-export analysis, pricing analysis is also included in the report to understand the product demand and service. Finally, it also provides end-user application analysis, which delivers revenue, growth percentage of the product across the different applications.
Global Acetaminophen (Paracetamol) Market 2020 | Genesis Biotech, M.M. Pharma, A …
The Global Acetaminophen (Paracetamol) Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Acetaminophen (Paracetamol) Market.The Key manufactures involved in this market
Global Ginkgetin Market 2019 - Hunan Nutramax, Shaanxi Pioneer Biotech, Xi'an So …
Ginkgetin is an extract from ginkgo biloba. Scope of the Report: Ginkgetin can dilate blood vessels, promote blood circulation, enhance immunity, and promote cerebral blood circulation and cell metabolism. The worldwide market for Ginkgetin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017. This report focuses on the Ginkgetin in global market, especially in North